WithdrawnNot Applicable

BPOI (Berlin Pediatric Oxygenation Index) - A New Predictor for Imminent Failure of HFNC in Children Avoiding Delayed NIV or Intubation

Stopped: Due to pandemia

0Started 2021-06-21

Plain-language summary

The investigators developed an index that integrates different flow-settings in High-flow nasal cannula (HFNC) therapy with non-invasively measured clinical parameters of oxygenation in pediatric patients. This observational study is designed to evaluate this index and to determine a cut-off value for imminent HFNC failure.

Who can participate

Age range28 Days – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with respiratory failure and indication für High-flow nasal cannula therapy * Patients aged between 4 1/7 weeks and 18 years * Patients who were treated between 01/01/2017 and 28/02/2021 in the Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine at Campus Virchow- Klinikum, Charité - Universitätsmedizin Berlin Exclusion Criteria: * Patients aged between 1 and 27 days (neonatal period) * Patients with congenital cyanotic heart defects * Patients after or in the course of haematopoetic stem cell transplantation * Patients with ambulatory respiratory support

What they're measuring

BPOI (Berlin Pediatric Oxygenation Index)

Timeframe: 01.01.2017-28.02.2021

Trial details

NCT IDNCT04895332

SponsorCharite University, Berlin, Germany

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Respiratory Failure (Pediatric Patients) trials